美国先天性心脏病儿童注意缺陷多动障碍患病率与治疗:全国调查分析
本研究汇总2020-2023年NSCH数据,纳入3-17岁儿童169584名,比较有或无家长报告先天性心脏病(CHD)儿童的注意缺陷多动障碍(ADHD)患病率。结果显示CHD儿童ADHD患病率显著更高(18.4% vs 10.7%,P<0.05),12-14岁青少年中近三分之一。CHD儿童接受ADHD药物治疗和行为干预的比例与无CHD儿童相似。
要点
- CHD儿童ADHD患病率显著高于无CHD儿童(18.4% vs 10.7%,P<0.05)。
- 12-14岁CHD青少年ADHD患病率达26.8%,接近三分之一。
- CHD儿童ADHD药物治疗和行为干预比例与无CHD儿童相似。
核心结论
- CHD儿童家长报告ADHD患病率高于无CHD同龄人,12-14岁青少年中近三分之一。
- CHD儿童接受ADHD治疗的比例与无CHD儿童相当。
研究设计与样本
- 汇总2020-2023年NSCH数据,纳入3-17岁儿童169584名,按家长报告CHD分组比较ADHD患病率。
- 采用多变量回归模型评估有或无CHD儿童中ADHD的社会人口学风险因素。
主要发现
- 多变量校正后,CHD儿童ADHD患病率显著高于无CHD儿童(18.4% vs 10.7%,P<0.05)。
- CHD儿童各年龄段ADHD患病率:3-5岁1.8%,6-8岁13.1%,9-11岁26.8%,12-14岁25.5%,15-17岁25.0%,调查年份间无显著差异。
- 在有和无CHD儿童中,较大年龄、男性、早产、家长报告健康状况较差和放弃医疗均与ADHD odds升高相关(P<0.05)。
- CHD儿童ADHD药物治疗率44.5%、行为干预率46.2%,无CHD儿童分别为50.7%和42.2%。
关键数值与推荐
- CHD儿童ADHD患病率18.4%,无CHD儿童10.7%(P<0.05)。
- CHD儿童各年龄段ADHD患病率:3-5岁1.8%,6-8岁13.1%,9-11岁26.8%,12-14岁25.5%,15-17岁25.0%。
- CHD儿童ADHD药物治疗44.5%、行为干预46.2%;无CHD儿童分别为50.7%和42.2%。
临床怎么用
- 对CHD儿童应加强神经发育监测,尤其关注学龄期和青少年ADHD症状。
- CHD儿童ADHD治疗模式与无CHD儿童相似,可参照常规ADHD管理。
局限性
- 结果基于家长报告,可能存在报告偏倚。
- 调查特异性可能影响估计的准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the intersection of congenital heart disease CHD and attention-deficit/hyperactivity disorder (ADHD,) in children we analyzed population-level data from the National Survey of Children's Health (NSCH). STUDY DESIGN: We pooled 2020-2023 NSCH data for children aged 3-17 years old (N = 169,584) with and without parent-reported CHD and compared ADHD prevalence between these groups. Multivariable regression models assessed social and demographic risk factors for ADHD in children with and without CHD. RESULTS: After multivariable correction, children with CHD had significantly higher prevalence of parent-reported ADHD than those without CHD (18.4% vs 10.7%, P < 0.05), with age-specific prevalence of 1.8% (ages 3-5), 13.1% (ages 6-8), 26.8% (ages 9-11), 25.5% (ages 12-14), and 25.0% (ages 15-17), with no significant differences across survey years. In weighted multivariable logistic regression, older age, male sex, prematurity, poorer parent-reported child health status, and foregone healthcare were associated with higher odds of ADHD in children with and without CHD (P < 0.05). Children with current CHD received treatment for ADHD with medication (44.5%) and behavioral intervention (46.2%) at similar prevalence to children without CHD (50.7% and 42.2%, respectively). CONCLUSIONS: Children with CHD had higher parent-reported ADHD prevalence than peers without CHD, including nearly one in three adolescents aged 12-14. Children with CHD received ADHD treatments at prevalence comparable with those without CHD. Although limited by parent report and survey specificity, these national estimates highlight elevated ADHD prevalence in children with CHD and support strengthened neurodevelopmental surveillance guidelines.
引用
- Fawcett J, Zhang X, Bommersbach T, et al. Prevalence and Treatment of US Children with Congenital Heart Disease and ADHD: A National Survey Analysis. J Pediatr. 2026. PMID: 42785513. doi:10.1016/j.jpeds.2026.115348
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。